Zearalenone exposure may increase the risk of non-alcoholic fatty liver disease by activating CYP1B1-SCD1. // Current Research in Toxicology. – URL: https://www.sciencedirect.com/science/article/pii/S2666027X25000635?dgcid=rss_sd_all
Zearalenone exposure may increase the risk of non-alcoholic fatty liver disease by activating CYP1B1-SCD1. Current Research in Toxicology. https://www.sciencedirect.com/science/article/pii/S2666027X25000635?dgcid=rss_sd_all
“Zearalenone exposure may increase the risk of non-alcoholic fatty liver disease by activating CYP1B1-SCD1.” Current Research in Toxicology.
@article{article3255,
title = {Zearalenone exposure may increase the risk of non-alcoholic fatty liver disease by activating CYP1B1-SCD1},
journal = {Current Research in Toxicology},
url = {https://www.sciencedirect.com/science/article/pii/S2666027X25000635?dgcid=rss_sd_all}
}